225 related articles for article (PubMed ID: 23271894)
1. Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.
Kirino E
Patient Prefer Adherence; 2012; 6():853-61. PubMed ID: 23271894
[TBL] [Abstract][Full Text] [Related]
2. Escitalopram: a review of its use in the management of major depressive disorder in adults.
Garnock-Jones KP; McCormack PL
CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
[TBL] [Abstract][Full Text] [Related]
3. [Escitalopram for treatment of major depressive disorder in adults].
Llorca PM; Brousse G; Schwan R
Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
Ma D; Zhang Z; Zhang X; Li L
Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on escitalopram in the management of major depressive disorder.
Murdoch D; Keam SJ
CNS Drugs; 2006; 20(2):167-70. PubMed ID: 16478291
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram: a review of its use in the management of major depressive disorder.
Murdoch D; Keam SJ
Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of escitalopram in the treatment of major depressive disorder.
Ali MK; Lam RW
Neuropsychiatr Dis Treat; 2011; 7():39-49. PubMed ID: 21430793
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
13. Priorities in treating depression only.
Lam RW
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():25-9. PubMed ID: 24930686
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
Amada N; Hirose T; Suzuki M; Kakumoto Y; Futamura T; Maeda K; Kikuchi T
Neuropsychopharmacol Rep; 2023 Mar; 43(1):132-136. PubMed ID: 36649966
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
Peselow ED; Tobia G; Karamians R; Pizano D; IsHak WW
Psychiatry Res; 2015 Feb; 225(3):680-6. PubMed ID: 25496869
[TBL] [Abstract][Full Text] [Related]
16. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
[TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
[TBL] [Abstract][Full Text] [Related]
18. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.
Gorman JM; Korotzer A; Su G
CNS Spectr; 2002 Apr; 7(4 Suppl 1):40-4. PubMed ID: 15131492
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
